CBLL — CeriBell, Inc

CeriBell, Inc (CBLL) is a medical devices company listed on NASDAQ. It is led by Xingjuan Chao Ph.D., based in 360 North Pastoria Avenue, Sunnyvale, CA, United States, 94085, with about 281 employees. CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Latest reported CBLL revenue for 2025-09-30 was $22.6M. Net income was -$39.9M. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. CBLL currently screens at market cap $768.1M.

Use this CBLL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CBLL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CBLL SEC filings page. Lician reads the product cache first so this HTML stays unique to CeriBell, Inc even when a live quote feed is slow.